Mirum Pharmaceuticals (MIRM) Earnings Date, Estimates & Call Transcripts → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free MIRM Stock Alerts $25.04 -0.87 (-3.36%) (As of 05/8/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryLatest Earnings DateMay. 8ConfirmedConsensus EPS (May. 8) -$0.37 Listen to CallLatest SEC 10-Q Filing Get Mirum Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for MIRM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMIRM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MIRM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> Mirum Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.53)$0.05($0.24) Q2 20242($0.48)$0.14($0.17) Q3 20242($0.32)$0.20($0.06) Q4 20242($0.19)$0.25$0.03 FY 20248($1.52)$0.64 ($0.44)MIRM Earnings Date and InformationMirum Pharmaceuticals last posted its earnings results on May 8th, 2024. The reported $0.00 earnings per share for the quarter, beating analysts' consensus estimates of ($0.37) by $0.37. Mirum Pharmaceuticals has generated ($3.97) earnings per share over the last year (($3.97) diluted earnings per share). Earnings for Mirum Pharmaceuticals are expected to grow in the coming year, from ($1.34) to $0.80 per share. Mirum Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Wednesday, May 8th, 2024. Mirum Pharmaceuticals will be holding an earnings conference call on Wednesday, May 8th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More Mirum Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/8/2024Confirmed)-($0.37)----- 2/28/2024Q4 2023($0.34)($0.66)($0.32)($0.66)$66.73 million$69.55 million11/2/2023Q3 2023($0.64)($0.57)+$0.07($0.57)$34.31 million$47.73 million8/3/2023Q2 2023($0.81)($0.92)($0.11)$0.10$30.00 million$37.50 million5/4/2023Q1 2023($0.96)($0.80)+$0.16($0.80)$30.58 million$31.60 million3/8/2023Q4 2022($0.98)($0.99)($0.01)($0.99)$24.99 million$27.91 million11/9/2022Q3 2022($1.05)($1.02)+$0.03($1.02)$21.16 million$18.78 million Get the Latest News and Ratings for MIRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($1.05)($0.84)+$0.21($0.84)$15.67 million$17.48 million 5/5/2022Q1 2022($1.39)($1.17)+$0.22($1.17)$8.68 million$12.89 million 3/9/2022Q4 2021($0.61)($0.92)($0.31)($3.75)$76.60 million$3.14 million11/15/2021Q3 2021($1.63)($1.55)+$0.08($1.55)$5.00 million$5.00 million 8/5/2021Q2 2021($0.41)($1.45)($1.04)($1.45)$29.00 million$11.00 million Mirum Pharmaceuticals Earnings - Frequently Asked Questions When is Mirum Pharmaceuticals's earnings date? Mirum Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Wednesday, May 8th, 2024. Learn more on MIRM's earnings history. Did Mirum Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Mirum Pharmaceuticals (NASDAQ:MIRM) reported $0.00 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.37) by $0.37. Learn more on analysts' earnings estimate vs. MIRM's actual earnings. How can I listen to Mirum Pharmaceuticals's earnings conference call? The conference call for Mirum Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Mirum Pharmaceuticals generate each year? Mirum Pharmaceuticals (NASDAQ:MIRM) has a recorded annual revenue of $186.37 million. How much profit does Mirum Pharmaceuticals generate each year? Mirum Pharmaceuticals (NASDAQ:MIRM) has a recorded net income of -$163.41 million. MIRM has generated -$3.97 earnings per share over the last four quarters. What is Mirum Pharmaceuticals's EPS forecast for next year? Mirum Pharmaceuticals's earnings are expected to grow from ($1.34) per share to $0.80 per share in the next year. More Earnings Resources from MarketBeat Related Companies: Belite Bio Earnings Spyre Therapeutics Earnings Collegium Pharmaceutical Earnings Ironwood Pharmaceuticals Earnings Pacira BioSciences Earnings Ligand Pharmaceuticals Earnings Verona Pharma Earnings MannKind Earnings AbCellera Biologics Earnings Prothena Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:MIRM) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
